Cancel

Links to sites outside of takeda.com are provided as a resource to the audiences. Please note that Takeda is not responsible or liable for any third-party website and the website may not be appropriate for all audiences. 

To stay on the current website, select “Cancel”


Continue

You are leaving Takeda.com

Takeda - Global

EPD-3055 OneTrust Cookie

EPD-3519 Schema Script

EPD-2855 GTM Script

EPD-4037 Matomo Tag Manager

EPD-4268 Cookie Script Hack

View Takeda Pharmaceuticals' earnings results from the last quarter. Download statements and reports and listen to earnings announcements.

Last Quarter Financial Report | Takeda Investor Relations

#Quarterly Results FY2022 (April 2022-March 2023)


Divider Section Redesign

Developing critical andlife-saving medicines for those with rare and complex diseases

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam. Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Sed ut perspiciatis undeomnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam. Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.

## Quarter 4



### Reference Materials

*   [Clinical Trials Summary](https://assets-dam.takeda.com/raw/upload/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2022/clinical-trial-summary-may-2023.pdf) (updated May 11, 2023)

*   [Epidemiology Data](https://assets-dam.takeda.com/raw/upload/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2022/qr2022_q4_epi-data.pdf) (updated May 11, 2023)



Quarterly Results FY2022 (April 2022-March 2023)

Quarter 4

Reference Materials

Quarter 3

Quarter 2

Quarter 1

Archive